Flinton Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.07M | Sell |
13,384
-10,360
| -44% | -$827K | 0.03% | 308 |
|
|
2019
Q2 | $1.85M | Sell |
23,744
-11,760
| -33% | -$918K | 0.06% | 230 |
|
|
2019
Q1 | $4.17M | Sell |
35,504
-23,100
| -39% | -$2.71M | 0.14% | 135 |
|
|
2018
Q4 | $6.38M | Buy |
58,604
+4,116
| +8% | +$448K | 0.24% | 95 |
|
|
2018
Q3 | $6.97M | Buy |
54,488
+14,280
| +36% | +$1.83M | 0.22% | 104 |
|
|
2018
Q2 | $4.55M | Buy |
40,208
+8,288
| +26% | +$938K | 0.15% | 131 |
|
|
2018
Q1 | $3.59M | Buy |
31,920
+23,576
| +283% | +$2.65M | 0.12% | 153 |
|
|
2017
Q4 | $1.24M | Buy |
8,344
+3,220
| +63% | +$477K | 0.04% | 257 |
|
|
2017
Q3 | $600K | Sell |
5,124
-16,380
| -76% | -$1.92M | 0.02% | 370 |
|
|
2017
Q2 | $2.79M | Sell |
21,504
-7,868
| -27% | -$1.02M | 0.1% | 164 |
|
|
2017
Q1 | $3.98M | Sell |
29,372
-12,544
| -30% | -$1.7M | 0.15% | 128 |
|
|
2016
Q4 | $6.01M | Buy |
+41,916
| New | +$6.01M | 0.26% | 73 |
|